Cardiosignala Subsidiary Of Precordioris A Health Technology Company Based In Turkufinlandwith Operations In Palo Altocaliforniathe Company Focuses On Innovative Solutions For Heart Disease Detectionleveraging Over A Decade Of Research And Algorithm Developmentcardiosignal Utilizes Patented Gyrocardiography Technology That Employs Motion Sensors In Smartphones To Non Invasively Assess Cardiac Functiontheir Smartphone Application Allows Users To Monitor Heart Conditionsmaking It Suitable For Self Monitoring And Remote Carethe Company Is Actively Working With The Fda To Launch Remote Cardiac Care Solutions In The Us Marketcardiosignal Has Collaborated With Prestigious Institutions Like Stanford University And Has Partnered With Jiseki Health To Enhance Remote Cardiac Care Serviceswith A Presence In Over 15 Countriescardiosignal Is Recognized For Its Contributions To Heart Healthhaving Received The American Heart Associationae S Empowered To Serve Program Grant Awardthe Company Is Led By A Dedicated Team Of Over 30 Professionalsincluding Ceo Juuso Blomster And Chief Technology Officer Ilkka Korhonen
